2009The Chinese Journal of Modern Applied PharmacyRequires access

Pharmacokinetics and Salivary Distribution of Baicalin in Shuanghuanglian at Different Doses Administration

Hua Han

Open publisher page 0 citations

Abstract

OBJECTIVE To identify pharmacokinetics and salivary distribution of baicalin after different doses administration of Shuanghuanglian injection to rats.METHODSEach rat was given a dose of Shuanghuanglian injection via the vein.An RP-HPLC method was used to determine the concentrations of baicalin in plasma and saliva.Pharmacokinetic model and parameters were analyzed by pharmacokinetics program MULTI97V10.RESULTSBaicalin showed two compartment model after administration of Shuanghuanglian at high,medium and low-dose(740,555,370 mg·kg-1) and the main parameters of pharmacokinetics in each dose were as follows:t1/2=(0.79±0.12)h,AUC=(1.30±0.13)mg·h·mL-1,Vc=(0.21±0.036)L,CL=(0.19±0.019)L·h-1;t1/2=(1.52±0.14)h,AUC=(1.22±0.20)mg·h·mL-1,Vc=(0.36±0.04)L,CL=(0.16±0.030)L·h-1;t1/2=(0.34±0.021)h,AUC=(0.22±0.004)mg·h·mL-1,Vc=(0.33±0.027)L,CL=(0.66±0.014)L·h-1.The salivary level of baicalin in high-dose was within 0.11-0.78 μg·mL-1.CONCLUSIONBecause AUC of baicalin was not increased proportionally with the doses of Shuanghuanglian,it was suggested that baicalin would present nonlinear pharmacokinetics.Baicalin was excreted into saliva much more lowly than blood.

About this research paper

What this paper is about

OBJECTIVE To identify pharmacokinetics and salivary distribution of baicalin after different doses administration of Shuanghuanglian injection to rats.METHODSEach rat was given a dose of Shuanghuanglian injection via the vein.An RP-HPLC method was used to determine the concentrations of baicalin in plasma and saliva.Pharmacokinetic model and parameters were analyzed by pharmacokinetics program MULTI97V10.RESULTSBaicalin showed two compartment model after administration of Shuanghuanglian at high,medium and low-dose(740,555,370 mg·kg-1) and the main parameters of pharmacokinetics in each dose were as follows:t1/2=(0.79±0.12)h,AUC=(1.30±0.13)mg·h·mL-1,Vc=(0.21±0.036)L,CL=(0.19±0.019)L·h-1;t1/2=(1.52±0.14)h,AUC=(1.22±0.20)mg·h·mL-1,Vc=(0.36±0.04)L,CL=(0.16±0.030)L·h-1;t1/2=(0.34±0.021)h,AUC=(0.22±0.004)mg·h·mL-1,Vc=(0.33±0.027)L,CL=(0.66±0.014)L·h-1.The salivary level of baicalin in high-dose was within 0.11-0.78 μg·mL-1.CONCLUSIONBecause AUC of baicalin was not increased proportionally with the doses of Shuanghuanglian,it was suggested that baicalin would present nonlinear pharmacokinetics.Baicalin was excreted into saliva much more lowly than blood.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To identify pharmacokinetics and salivary distribution of baicalin after different doses administration of Shuanghuanglian injection to rats.METHODSEach rat was given a dose of Shuanghuanglian injection via the vein.An RP-HPLC method was used to determine the concentrations of baicalin in plasma and saliva.Pharmacokinetic model and parameters were analyzed by pharmacokinetics program MULTI97V10.RESULTSBaicalin showed two compartment model after administration of Shuanghuanglian at high,medium and low-dose(740,555,370 mg·kg-1) and the main parameters of pharmacokinetics in each dose were as follows:t1/2=(0.79±0.12)h,AUC=(1.30±0.13)mg·h·mL-1,Vc=(0.21±0.036)L,CL=(0.19±0.019)L·h-1;t1/2=(1.52±0.14)h,AUC=(1.22±0.20)mg·h·mL-1,Vc=(0.36±0.04)L,CL=(0.16±0.030)L·h-1;t1/2=(0.34±0.021)h,AUC=(0.22±0.004)mg·h·mL-1,Vc=(0.33±0.027)L,CL=(0.66±0.014)L·h-1.The salivary level of baicalin in high-dose was within 0.11-0.78 μg·mL-1.CONCLUSIONBecause AUC of baicalin was not increased proportionally with the doses of Shuanghuanglian,it was suggested that baicalin would present nonlinear pharmacokinetics.Baicalin was excreted into saliva much more lowly than blood.

Key concepts: Baicalin, Pharmacokinetics, Pharmacology, Saliva, Distribution (mathematics), Chemistry, High-performance liquid chromatography, Oral administration

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics and Salivary Distribution of Baicalin in Shuanghuanglian at Different Doses Administration — Research Paper | ScholarLens